General MedicationsORALStandard
XENICAL
ORLISTAT
Standard Dose
120MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview XENICAL is listed in Drugs@FDA under application 020766 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ORLISTAT Form and strength CAPSULE;ORAL - 120MG Sponsor CHEPLAPHARM Submission history Latest submission status date: 2022-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview XENICAL is listed in Drugs@FDA under application 020766 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ORLISTAT Form and strength CAPSULE;ORAL - 120MG Sponsor CHEPLAPHARM Submission history Latest submission status date: 2022-11-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.